2. Academic Validation
  3. Actions of a picomolar short-acting S1P₁ agonist in S1P₁-eGFP knock-in mice

Actions of a picomolar short-acting S1P₁ agonist in S1P₁-eGFP knock-in mice

  • Nat Chem Biol. 2011 May;7(5):254-6. doi: 10.1038/nchembio.547.
Stuart M Cahalan 1,  Pedro J Gonzalez-Cabrera,  Gor Sarkisyan,  Nhan Nguyen,  Marie-Therese Schaeffer,  Liming Huang,  Adam Yeager,  Bryan Clemons,  Fiona Scott,  Hugh Rosen
Affiliations

Affiliation

  • 1 Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA.
PMID: 21445057 DOI: 10.1038/nchembio.547
Abstract

Sphingosine 1-phosphate receptor 1 (S1P(1)) is critical for lymphocyte recirculation and is a clinical target for treatment of multiple sclerosis. By generating a short-duration S1P(1) agonist and mice in which fluorescently tagged S1P(1) replaces wild-type receptor, we elucidate physiological and agonist-perturbed changes in expression of S1P(1) at a subcellular level in vivo. We demonstrate differential downregulation of S1P(1) on lymphocytes and endothelia after agonist treatment.

Figures
Products